Sandoz (SDZNY) announced a number of steps to resolve the US Generic Drug Antitrust Class Action Litigation. Following the previously announced settlements with the US Department of Justice in ...

After months of deliberation, and no formal offers from a buyer, Novartis has decided that its generics business Sandoz will be spun out into an independent company. The Swiss pharma group said ...

Sandoz expects the settlement, which is subject to approval from a Pennsylvania federal court, to be finalized before the end of the year. Those involved in the settlement have the right to opt ...

Swiss generic medicines firm Sandoz on Tuesday said it had reached a $275 million settlement with plaintiffs in a legacy US generic drug antitrust lawsuit. Sandoz and subsidiary Fougera ...

This leaflet answers some common questions about Carbamazepine Sandoz. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

(RTTNews) - Sandoz Group AG (SDZNY), a Swiss generic and biosimilar medicines maker, announced Tuesday that it has agreed to pay $275 million to the class of end payer plaintiffs to resolve legacy ...